Cellular senescence mediates fibrotic pulmonary disease
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index; 18 of the 31 sources its claims cite were checked for support.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal disease characterized by interstitial remodelling, leading to compromised lung function. Cellular senescence markers are detectable within IPF lung tissue and senescent cell deletion rejuvenates pulmonary health in aged mice. Whether and how senescent cells regulate IPF or if their removal may be an efficacious intervention strategy is unknown. Here we demonstrate elevated abundance of senescence biomarkers in IPF lung, with p16 expression increasing with disease severity. We show that the secretome of senescent fibroblasts, which are selectively killed by a senolytic cocktail, dasatinib plus quercetin (DQ), is fibrogenic. Leveraging the bleomycin-injury IPF model, we demonstrate that early-intervention suicide-gene-mediated senescent cell ablation improves pulmonary function and physical health, although lung fibrosis is visibly unaltered. DQ treatment replicates benefits of transgenic clearance. Thus, our findings establish that fibrotic lung disease is mediated, in part, by senescent cells, which can be targeted to improve health and function.
Overview
CoChat Summary
## TL;DR
This study links cellular senescence to idiopathic pulmonary fibrosis (IPF) by showing that senescence markers rise with disease severity in human lung tissue and that senescent fibroblast secretions are profibrotic. In a bleomycin mouse model, clearing senescent cells improved lung function and physical health, and dasatinib plus quercetin (DQ) reproduced the benefits of transgenic senescent-cell ablation.
## Key findings
- In human IPF lung samples, CDKN2A (p16) was significantly upregulated and increased with disease severity; higher pulmonary p16 expression correlated with reduced FVC, diffusion capacity, and SF-12 physical component score.
- In IPF tissue, p16-positive epithelial cells and fibroblasts were found in fibroblastic foci and honeycomb lung, and TAF-positive cells / γH2A.X foci were significantly increased relative to controls.
- In the bleomycin mouse model, lung injury increased whole-lung p16 expression by threefold, and SASP-related transcripts including Mcp1, Il6, Mmp12, Col1a1, and Tgfβ rose after bleomycin exposure.
- Senescent fibroblast conditioned medium was fibrogenic in vitro: it increased αSMA positivity to 62% vs 21% with control conditioned medium, increased traction forces, and induced fibrosis genes such as ACTA2, COL1A1, COL1A2, and FN1.
- In mice, senescent-cell clearance improved pulmonary/physical outcomes: Penh rose about twofold after bleomycin and was diminished by AP or DQ; lung compliance fell by 40% in vehicle-treated bleomycin mice but only 15% with AP or DQ; body weight loss averaged 3.6 g with vehicle vs about 1.6 g with AP/DQ; treadmill distance to exhaustion was >37% further with AP/DQ than vehicle.
- The paper states that histological fibrosis reductions did not reach statistical significance, despite functional benefits.
## Methods
- Human data came from LTRC control and IPF lung tissue samples, including microarray and RNA-seq datasets; the paper reports IPF n=27 and control n=10 for p16 immunohistochemistry, and transcriptome analyses stratified by FVC severity.
- The mouse study used male Ink-Attac mice given aerosolized intratracheal bleomycin (2 U/kg) or PBS, then randomized to AP20187, dasatinib plus quercetin (DQ), or vehicle at either an early prevention timepoint or a later treatment timepoint.
- Analyses included FACS of lung fibroblasts, epithelial cells, and endothelial cells, immunohistochemistry / immunofluorescence, conditioned-medium assays in IMR90 fibroblasts, traction force microscopy, RT-PCR, and statistical modeling with regression and multiple-comparison correction.
## Limitations
- The paper states that the bleomycin model spontaneously resolves, with resolution varying by factors such as genetic background and microbiome, which limits interpretation of late-stage effects.
- The authors state that they could not disentangle senescence-dependent from senescence-independent events governing fibrosis resolution.
- Lung fibrosis histology did not improve significantly after senescent-cell clearance, despite functional gains; the paper itself notes this may reflect the short time course and heterogeneity of the bleomycin model.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
13 Valid · 0 Not valid · 8 Not checked · 94 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Through secretion of the senescence-associated secretory phenotype (SASP), a broad repertoire of cytokines, chemokines, matrix remodelling proteases and growth factors, senescent cells paracrinely promote proliferation and tissue deterioration8.”
§ Cellular senescence mediates fibrotic pulmonary disease > Abstract
What the sources say
- Partly supportedcites [8] van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439–446 (2014). sourceExperimental — accuracy not yet measured
In “Senescence is a multi-step evolving process” (page unavailable), the paper says SASP-mediated paracrine signalling affects cell proliferation. In “Senescence in ageing and age-related disease” (page unavailable), it says SASP components are thought to promote proliferation of neoplastic cells and may intensify age-related tissue deterioration. The citing sentence presents those qualified effects as established and general. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cellular senescence is an evolutionarily conserved state of stable replicative arrest induced by pro-ageing stressors also implicated in IPF pathogenesis, including telomere attrition, oxidative stress, DNA damage and proteome instability.”
§ Cellular senescence mediates fibrotic pulmonary disease > Abstract
What the sources say
- Partly supportedcites [8] van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439–446 (2014). sourceExperimental — accuracy not yet measured
The Abstract and 'Senescence is a multi-step evolving process' describe growth arrest, including a transition to stable cell-cycle arrest. 'Causes and effector pathways of senescence' identifies telomere erosion, DNA lesions, reactive oxygen species and proteotoxic stress as senescence-related stressors. The cited passages do not establish that senescence is evolutionarily conserved or that these stressors are implicated in IPF pathogenesis; the paper also distinguishes replicative senescence from other forms of senescence. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Critically, impaired capacity to resolve fibrotic bleomycin injury has been associated with accumulation of apoptosis-resistant, senescent myofibroblasts3.”
§ Cellular senescence mediates fibrotic pulmonary disease > Results > Senescent cell retention impairs fibrosis resolution Taken together, our in vivo results strongly support the hypothesis that elimination of senescent cells improves fibrotic pulmonary disease when treatment is initiated at the onset of pathogenesis. We next sought to test the clinically important question of whether senescent cell clearance provides comparable benefit when initiated at a timepoint when pathology has fully developed. Ink-Attac mice contained a strong senescent signature in lung fibroblasts and epithelial cells 2 weeks post-bleomycin challenge (Fig. 2), a timepoint of well-established fibrotic remodelling in the lung15. Accordingly, we administered a single dose of bleomycin or PBS through aerosolized intratracheal administration to Ink-Attac mice. Two weeks post challenge, we randomized bleomycin-exposed mice to AP, DQ or vehicle treatment groups based on change in body weight and non-invasively measured airway resistance (Penh). Mice were treated for 2 weeks and were killed 4 weeks following bleomycin or PBS exposure (Fig. 5a). Body weight monitoring revealed that, similar to our previous experiments (Fig. 4f), mice that received bleomycin lost substantial body mass, relative to mice that received PBS. Upon treatment initiation on day 14, mean body weight of mice treated with AP plateaued, while vehicle-treated, bleomycin-exposed counterparts continued to lose weight (Fig. 5a), suggestive of physical benefit afforded by senescent cell clearance, even when treatment is initiated in later-stage disease. Spontaneous resolution is an inherent limitation of the bleomycin IPF model, with the rate and variability of bleomycin-induced pathology resolution dependent on complex factors, including genetic background and the microbiome3839. Indeed, both endpoint compliance (Supplementary Fig. 6) and comparison of Penh airway resistance at endpoint (4 weeks post challenge) to measures taken at the treatment randomization timepoint (2 weeks post challenge) revealed appreciable, albeit variable, improvement in all bleomycin-exposed groups, including vehicle-treated mice, with AP-treated mice showing greatest improvement (Fig. 5b). Thus, in our hands, the 3–4-week-period following a single bleomycin exposure represents a pivotal window of natural resolution (Figs 4 and 5a,b). Critically, impaired capacity to resolve fibrotic bleomycin injury has been associated with accumulation of apoptosis-resistant, senescent myofibroblasts3. As we were unable to disentangle senescence-dependent and -independent events governing resolution, we queried whether p16 expression, a measure of senescent burden, was associated with indicators of disease persistence. Impaired lung function, as measured by endpoint airway resistance (Penh) (Fig. 5c) and airway compliance (Fig. 5d), correlated significantly with p16 transcript abundance. This finding is consistent with associations drawn in humans, in which increased p16 expression correlated significantly with reduced FVC, pulmonary diffusion capacity and physical function (Supplementary Fig. 1). Similarly, in bleomycin-exposed mice, expression of the inflammatory and fibrogenic SASP factors Mcp1 (Fig. 5e), Pai1 (Fig. 5f), Mmp10 (Fig. 5g) and Col1a1 (Fig. 5h) robustly correlated with p16 transcriptional activation. These results further support the notion that the presence and activities of senescent cells may dictate resolution capacity following bleomycin-induced pathology.
What the sources say
- Supportedcites [3] Hecker, L. et al. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci. Transl. Med. 6, 231ra247 (2014). source
The Introduction states that aged mice have impaired fibrosis resolution associated with senescent, apoptosis-resistant myofibroblasts. The Results identify bleomycin as the lung-injury model and report accumulation of senescent myofibroblasts in aged mice with persistent fibrosis. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Senescence was confirmed by expression profiling (p16, SASP factors) and/or SA-β-gal staining32 21 days post radiation.”
§ Cellular senescence mediates fibrotic pulmonary disease > Methods > Cell culture For experiments employing radiation-induced senescence, IMR90 (passages 5–7; ATCC, catalogue number CCL-186) and primary human fibroblasts (passages 3–6) were exposed to 10 Gy radiation or sham conditions using a RS2000 X-Ray Irradiator (RAD Source Technologies, Suwanee, GA). Normal bronchial epithelial cells (passages 4–7, Lot 7F3000, Lonza, Walkersville, MD) were exposed to 5 Gy or sham conditions. Senescence was confirmed by expression profiling (p16, SASP factors) and/or SA-β-gal staining32 21 days post radiation. For SA-β-gal staining, cells were fixed for 10 min in 2% formaldehyde+0.2% glutaraldehyde in PBS at room temperature. Cells were rinsed with PBS and incubated overnight in SA-β-gal staining solution containing the following: 1 mg ml−1 X-gal, 40 mM citric acid/sodium phosphate buffer pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM sodium chloride and 2 mM magnesium chloride in water. Cells were then rinsed in PBS and stored at 4 °C until imaging. Media applied 20 days post irradiation (or sham) was collected 24 h later and was diluted with NCM to reflect equivalent source cell concentrations. ProcartaPlex immunoassays (Affymetrix eBioscience) were used for CM secretome composition assessment, according to the manufacturer's specifications. Non-irradiated IMR90 cells (passages 5–7) were treated with NCM, NCM+2 ng ml−1 TGFβ, CCM or SASP-CM and applied to downstream analyses as indicated. Primary human fibroblasts collected from human patients were authenticated through αSMA staining. For senolytic treatment, sham and irradiated primary human fibroblasts were treated with indicated concentrations of DQ or navitoclax for 3 days, starting at day 20 post irradiation or sham exposure. Cell viability after drug treatment was measured by ATPLite Kits (PerkinElmer; Waltham, MA) performed according the manufacturer's instructions. Luminescence was read using a multi-scan plate reader (Fisher). For experiments utilizing etoposide-induced senescence, IMR90 human lung fibroblasts (passage 10; ATCC) were treated for 48 h with 20 μM etoposide (Enzo Life Sciences, Farmingdale, NY). Etoposide was removed and replaced with fresh media. Six days after etoposide removal, approximately 60% of IMR90 cells were SA-β-gal positive. Cells were treated for 48 h with 20 μM D+15 μM Q or 10 μM navitoclax (or untreated control) and the percentage of SA-β-gal-positive cells was determined using a C12FDG-based senescence assay described as follows46. Briefly, etoposide-treated senescent IMR90 cells were seeded at a concentration of 5 × 103 cells per well in 96-well plates 24 h before treatment. Following addition of the drugs, the cells were incubated for 48 h under 20% O2 oxygen conditions. For fluorescence analysis of SA-β-gal activity, cells were incubated for 1 h with 100 nM Bafilomycin A1 (Calbiochem, San Diego, CA). Next, 10 μM C12FDG (Setareh Biotech, Eugene, OR) was added to the culture medium and the cells were incubated for 1.5–2 h. Ten minutes before analysis, the DNA intercalating Hoechst dye (2 μg ml−1) was added to the cells. For quantitative analysis of cell number (Hoechst staining) and number of C12FDG-positive senescent cells, a laser-based line scanning confocal imager IN Cell 6000 Analyzer was used. All samples were analysed in duplicate with three to five fields per well.
What the sources say
- Partly supportedcites [32] Baker, D. J. et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530, 184–189 (2016). sourceExperimental — accuracy not yet measured
In “ATTAC clears senescent adipocyte progenitor cells” (page unavailable), the paper identifies cells using p16 expression, other senescence markers, and SAβ-Gal staining. It studies naturally occurring senescent cells, however, and does not support the claim’s 21-day post-radiation condition. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Importantly, CM collected from irradiated bronchiolar epithelial cells did not activate a fibrogenic response, as measured by αSMA fibrotic activation of naive IMR90 cells (Supplementary Fig. 2), suggesting that cell-type-specific SASP composition may differentially affect pathological phenotypes within the lung.”
§ Cellular senescence mediates fibrotic pulmonary disease > Results > The secretome of senescent fibroblasts is profibrotic
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
61 more claims
Create a free account to see all 115 claims and to verify the 5 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 26
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is in agreement with a recent report showing that the removal of senescent cells expressing high levels of p16INK4a can lead to fibrosis in mice101, whereas small-molecule senolytics appear to reduce fibrosis in several mouse tissues22,71,73,75,102.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in a mouse model of idiopathic pulmonary fibrosis (IPF), D + Q treatment improved lung compliance and reduced frailty71.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with IPF accumulate TAFs and senescence markers in lungs that increase with disease severity and activate SASP52.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of various natural flavonoids, including quercetin and fisetin, either alone or in combination with dasatinib, a pan-tyrosine kinase inhibitor, can stimulate senolysis in a variety of contexts in vitro and in vivo199,207–210.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [199]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [33]
Experimental — accuracy not yet measured
35 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 2×
“Attenuation of age-related pathologies and extension of lifespan in chronologically aged mice has been demonstrated using the same transgenic strategy 32–34 , and improvements in lung structure and function in aged mice have recently been demonstrated using a similar suicide-gene strategy 20 .”
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 2×
“An alternative approach to transgenic senescent cell clearance is senolytics 21,22 , which may be a tractable treatment option for humans.”
Self-citationDesmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Cited by
Items 401–500 of 1,619
Kopf, S., Kumar, V., Κender, Ζ., Han, Z., Fleming, T., Herzig, S., & Nawroth, P. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.765201 · Cited by 64
“Aging is also a risk factor for IPF, and it is not surprising that cellular senescence plays a role in fibrotic pulmonary disease (98).”
BackgroundAlveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Zhou, S., Zhu, J., Zhou, P., & Gu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999600 · Cited by 61
“Significantly, senescent AT2 cell clearance reduces the expression of SASP factors such as IL-6, TGF-β, and MMP12, which play a decisive role in the regulation of pulmonary fibrosis and lung function (Jeon et al., 2017; Schafer et al., 2017; Prata et al., 2018).”
BackgroundMagkouta, S., Veroutis, D., Papaspyropoulos, A., Georgiou, M., Lougiakis, N., Pippa, Ν., Havaki, S., Palaiologou, A., Thanos, D.-F., Kambas, K., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00747-4 · Cited by 67
Herrera, J., Beisang, D. J., Peterson, M., Forster, C., Gilbertsen, A., Benyumov, A., Smith, K., Korenczuk, C. E., Barocas, V. H., Guenther, K., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201709-1823oc · Cited by 56
“Recent data indicate that cellular senescence markers are expressed within the fibroblastic focus (41), and there is extensive crosstalk between DNA damage repair and cellular senescence (42).”
BackgroundLiu, T., Santos, F. G. D. L., Zhao, Y., Wu, Z. B., Rinke, A. E., Kim, K. K., & Phan, S. H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006615 · Cited by 59
“Lung cells from IPF patients exhibit a reduction in Sirt1 expression (37, 57) and evidence of cellular senescence, as manifested by induction of p53, p21, and/or p16, whose levels of expression correlate with the severity of fibrotic lung disease (58).”
BackgroundTargeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Zmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 56
MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells
Potter, M. L., Hill, W., Isales, C. M., Hamrick, M. W., & Fulzele, S. (2020) · Bone · doi:10.1016/j.bone.2020.115679 · Cited by 61
The mitochondria in lung fibrosis: friend or foe?
Malsin, E. S., & Kamp, D. W. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.005 · Cited by 58
DNA damage responses in ageing
da Silva, P. F. L., & Schumacher, B. (2019) · Open Biology · doi:10.1098/rsob.190168 · Cited by 55
“Conversely, removal of senescent cells with senolytic drug treatments has been shown to improve several healthspan parameters [75] and to improve tissue function in animal models of pulmonary fibrosis [115], atherosclerosis [118], hepatic steatosis [117] and obesity [119].”
BackgroundZhang, L., Tong, X., Huang, J., Wu, M., Zhang, S., Wang, D., Liu, S., & Fan, H. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.553690 · Cited by 60
Restored immune cell functions upon clearance of senescence in the irradiated splenic environment
Palacio, L., Goyer, M., Maggiorani, D., Espinosa, A., Villeneuve, N., Bourbonnais, S., Moquin‐Beaudry, G., Le, O., Demaria, M., Davalos, A. R., et al. (2019) · Aging Cell · doi:10.1111/acel.12971 · Cited by 54
“Significantly, genetic or pharmacological elimination of senescent cells reverses the onset of aging and asso‐ ciated pathologies in mice (Baker et al., 2016; Farr et al., 2017; Jeon et al., 2017; Ogrodnik et al., 2017; Schafer et al., 2017).”
BackgroundSenescent cell accumulation mechanisms inferred from parabiosis
Karin, O., & Alon, U. (2021) · GeroScience · doi:10.1007/s11357-020-00286-x · Cited by 48
Kaur, G., Muthumalage, T., & Rahman, I. (2023) · Aging Cell · doi:10.1111/acel.13850 · Cited by 53
“…senescence in IPF has been studied and there is evidence that targeting senescent cells could help improve the clinical outcomes in IPF, the role of cellular senescence in the development and progress of COPD is still unknown (Kellogg et al., 2021; Mercado et al., 2015; Schafer et al., 2017).”
BackgroundRoxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells
Zhang, X., Dong, Y., Li, W.-C., Tang, B., Li, J., & Zang, Y. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00618-3 · Cited by 58
CD38 in the age of COVID-19: a medical perspective
Horenstein, A. L., Faini, A. C., & Malavasi, F. (2021) · Physiological Reviews · doi:10.1152/physrev.00046.2020 · Cited by 59
Wijayasiri, P., Astbury, S., Kaye, P., Oakley, F., Alexander, G. J., Kendall, T. J., & Aravinthan, A. D. (2022) · Cells · doi:10.3390/cells11142221 · Cited by 54
Nintedanib induces senolytic effect via STAT3 inhibition
Cho, H.-J., Hwang, J.-A., Yang, E. J., Kim, E.-C., Kim, J., Kim, S. Y., Kim, Y. Z., Park, S. C., & Lee, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05207-8 · Cited by 65
“Because body weight loss is a key indicator of pathological severity in bleomycin-treated lung injury [25, 47], we first measured the change in the body weight of mice treated with senolytic drugs.”
BackgroundMethodInhaled deep eutectic solvent based-nanoemulsion of pirfenidone in idiopathic pulmonary fibrosis
Kang, J., Yang, M.-S., Kwon, T. K., Kim, D., & Park, C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.045 · Cited by 53
Lee, J. Y., Reyes, N. S., Ravishankar, S., Zhou, M., Krasilnikov, M., Ringler, C., Pohan, G., Wilson, C., Ang, K. K. H., Wolters, P. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci173371 · Cited by 63
“The goal of the primary screen was to identify the most potent compounds that killed was no evidence that this animal model improved standard fibrotic endpoints such as hydroxyproline content (21).”
InfluentialSundar, I. K., Rashid, K., Gerloff, J., Li, D., & Rahman, I. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0390oc · Cited by 53
Martyanov, V., Whitfield, M. L., & Varga, J. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40934 · Cited by 52
“Indeed, this mechanistic scenario closely parallels recent experimental observations in an animal model of bleomycininduced lung fibrosis, where pharmacologic clearance of senescent cells using dasatinib plus quercetin resulted in functional attenuation of the lung fibrosis (8).”
ResultThe role of lipid-based signalling in wound healing and senescence
Pils, V., Terlecki‐Ζaniewicz, L., Schosserer, M., Grillari, J., & Lämmermann, I. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111527 · Cited by 60
Clinical Trials Targeting Aging
Nielsen, J. L., Bakula, D., & Scheibye‐Knudsen, M. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.820215 · Cited by 61
“Studies of idiopathic pulmonary fibrosis mice indicate positive effects of the senolytic drugs dasatinib and quercetin (D + Q) on pulmonary and physical function (Schafer et al., 2017) and a study with idiopathic pulmonary fibrosis patients, mainly investigating the safety of D + Q treatment, suggests beneficial effec…”
BackgroundTranslating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics
Riessland, M., & Orr, M. E. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.104 · Cited by 52
“In fact, since D+Q targets a range of biological pathways in diverse tissues, it is generally difficult to attribute cell type-specific biological effects to the senolysis itself (45, 103, 112).”
BackgroundResultThe role of cellular senescence in ovarian aging
Hense, J. D., Isola, J. V. V., Garcia, D. N., Magalhães, L. S., Masternak, M. M., Stout, M. B., & Schneider, A. (2024) · npj Aging · doi:10.1038/s41514-024-00157-1 · Cited by 71
Distal lung epithelial progenitor cell function declines with age
Watson, J. K., Sanders, P., Dunmore, R., Rosignoli, G., Julé, Y., Rawlins, E. L., Mustelin, T., May, R., Clarke, D., & Finch, D. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-66966-y · Cited by 51
Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria
Fan, Y., Cheng, J., Zeng, H., & Shao, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.593630 · Cited by 51
Reactive Oxygen Species Detection in Senescent Cells
Victorelli, S. G., & Passos, J. F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_3 · Cited by 55
Self-citationSenolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells
Lafontaine, J., Cardin, G. B., Malaquin, N., Boisvert, J.-S., Rodier, F., & Wong, P. (2021) · Cancers · doi:10.3390/cancers13030386 · Cited by 54
“Nevertheless, chronic RT side effects, such a fibrosis occur in up to 28% of long-term cancer survivors [85,86].”
BackgroundMing, X., Yang, Z. R., Huang, Y., Wang, Z., Zhang, Q., Lu, C., Sun, Y., Chen, Y., Zhang, L., Wu, J., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00750-9 · Cited by 61
“Senes-cent cell accumulation in the mouse lung can easily lead to lung injury, making it an ideal model for studying senescent cell elimination 44 .”
Kuehl, T., & Lagares, D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.020 · Cited by 50
“showed proapoptotic effects on senescent lung myofibroblasts, major effector cells in idiopathic pulmonary fibrosis (IPF), a fatal aging-associated lung disease [67].”
BackgroundSpontaneous Lung Fibrosis Resolution Reveals Novel Antifibrotic Regulators
Tan, Q., Link, P. A., Meridew, J. A., Pham, T. X., Caporarello, N., Ligresti, G., & Tschumperlin, D. J. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0396oc · Cited by 61
“Although recent studies have emphasized the role of apoptotic clearance of fibrogenic cells as a mechanism to terminate lung fibrosis (57, 58), our work highlights an accompanying prominent role for deactivation and provides a rich dataset from which to identify potential regulators of this deactivation process.”
BackgroundSelf-citationAging and Mesenchymal Stem Cells: Therapeutic Opportunities and Challenges in the Older Group
Chen, H., Liu, O., Chen, S., & Zhou, Y. (2021) · Gerontology · doi:10.1159/000516668 · Cited by 56
Liu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
“D + Q has shown potential in preclinical models for controlling diverse age-associated conditions including pulmonary fibrosis and neurodegeneration [344,345] along with promising activity in clinical trials.”
BackgroundMapping epidermal and dermal cellular senescence in human skin aging
Yu, G., Gânier, C., Allison, D. B., Tchkonia, T., Khosla, S., Kirkland, J. L., Lynch, M. D., & Wyles, S. P. (2024) · Aging Cell · doi:10.1111/acel.14358 · Cited by 62
Self-citationSenescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection
Wandrer, F., Han, B., Liebig, S., Schlue, J., Manns, M. P., Schulze‐Osthoff, K., & Bantel, H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14802 · Cited by 49
“In pulmonary fibrosis, it was shown that the SASP of senescent fibroblasts is profibrotic.(52) However, it is also conceivable that spatiotemporal differences in senescence in different cell types trigger the secretion of distinct SASP components, which might explain the controversy concerning profibrotic vs fibrinoly…”
BackgroundSenescence in Pulmonary Fibrosis: Between Aging and Exposure
Venosa, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606462 · Cited by 54
“Chemical exposure to pesticides, doxorubicin, bleomycin and radiation demonstrate that the added pressure provided by acute or chronic exposure accelerates stromal cell senescence, thereby contributing to the pathogenesis and progression of the fibrotic response (153, 160, 161).”
BackgroundResultDPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Herman, A. B., Tsitsipatis, D., Anerillas, C., Mazan-Mamczarz, K., Carr, A. E., Gregg, J. M., Wang, M., Zhang, J., Michel, M., Henry-Smith, C. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165933 · Cited by 50
Merkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 68
“In humans, senescent myofibroblasts from patients with IPF show elevation of p16 and p21.(50,51,55,136) Mechanistically, acquisition of a senescent MERKT ET AL.”
Senescent cardiac fibroblasts: A key role in cardiac fibrosis
Osorio, J. M., Espinoza-Pérez, C., Rimassa-Taré, C., Machuca, V., Bustos, J. O., Vallejos, M., Vargas, H., & Díaz-Araya, G. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166642 · Cited by 53
Zhang, L., Zhang, Y., Chang, F., Zhang, J., Wang, L., Yi, Z.-W., & Gao, G. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.129 · Cited by 49
Stojanović, S. D., Fuchs, M., Kunz, M., Xiao, K., Just, A., Pich, A., Bauersachs, J. K., Fiedler, J., Sedding, D., & Thum, T. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00520 · Cited by 53
Yao, L., Zhou, Y., Li, J., Wickens, L., Conforti, F., Rattu, A., Ibrahim, F. M., Alzetani, A., Marshall, B. G., Fletcher, S., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101096 · Cited by 75
“Three publicly available datasets (GSE139963 (9), GSE92592 (10), and GSE99621 (12)) were collected from Gene Expression Omnibus.”
InfluentialDiverse Roles of Cellular Senescence in Skeletal Muscle Inflammation, Regeneration, and Therapeutics
Saito, Y., & Chikenji, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739510 · Cited by 56
“…to muscle regeneration under physiological conditions and to ectopic tissue formation under pathological conditions (Joe et al., 2010; Uezumi et al., 2010; Murphy et al., 2011; Uezumi et al., 2011; Ito et al., 2013; Uezumi et al., 2014; Lemos et al., 2015; Scott et al., 2019; Theret et al., 2021).”
BackgroundThe role of MIF in chronic lung diseases: looking beyond inflammation
Florez-Sampedro, L., Soto-Gamez, A., Poelarends, G. J., & Melgert, B. N. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00521.2019 · Cited by 47
“In addition, a mouse study from Schafer and colleagues showed that bleomycin induces senescence in lung epithelial cells and lung fibroblasts and that the elimination of senescent cells improves pulmonary function and physical health (82).”
BackgroundZhang, C., Chen, L., Xie, C., Wang, F., Wang, J., Zhou, H., Liu, Q., Zeng, Z., Li, N., Huang, J., et al. (2023) · The EMBO Journal · doi:10.1038/s44318-023-00003-2 · Cited by 60
“In addition, clearance of senescent cells (p16-positive) improved phenotypes in bleomycin-induced lung fi brosis (Schafer et al, 2017).”
BackgroundLee, E., Carreras-Gallo, N., Lopez, L., Turner, L., Lin, A., Mendez, T. L., Went, H., Tomusiak, A., Verdin, E. M., Corley, M. J., et al. (2024) · Aging · doi:10.18632/aging.205581 · Cited by 59
“Combined treatment 56 with Dasatinib and Quercetin (DQ) has been demonstrated to decrease senescent cell burden 57 in humans in multiple tissues [12], [17]–[20]; improve pulmonary and physical function along 58 with survival in mice while lessening their age-dependent intervertebral disc degeneration [7], 59 [21], [22…”
BackgroundRodríguez, L. R., Emblom-Callahan, M. C., Chhina, M. K., Bui, S., Aljeburry, B., Tran, L. H., Novak, R., Lemma, M., Nathan, S. D., & Grant, G. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21889-7 · Cited by 50
Freeberg, M. A. T., Farhat, Y. M., Easa, A., Kallenbach, J. G., Malcolm, D. W., Buckley, M. R., Benoit, D. S. W., & Awad, H. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-24144-1 · Cited by 52
Mouse Models of Accelerated Cellular Senescence
Yousefzadeh, M. J., Melos, K. I., Angelini, L., Burd, C. E., Robbins, P. D., & Niedernhofer, L. J. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-8931-7_17 · Cited by 47
Self-citationMcCarthy, C. G., Wenceslau, C. F., Webb, R. C., & Joe, B. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz052 · Cited by 50
Potential Role of Cellular Senescence in Asthma
Wang, Z.-N., Su, R., Yang, B.-Y., Yang, K., Yang, L., Yan, Y., & Chen, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00059 · Cited by 51
Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence
Abdelgawad, I. Y., Sadak, K. T., Lone, D. W., Dabour, M. S., Niedernhofer, L. J., & Zordoky, B. N. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107751 · Cited by 50
Geng, F., Xu, M., Zhao, L., Zhang, H., Li, J., Jin, F., Li, Y., Li, T., Yang, X., Li, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.912029 · Cited by 50
Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury
Lu, Y., Jarrahi, A., Moore, N. D., Bartoli, M., Brann, D. W., Baban, B., & Dhandapani, K. M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106090 · Cited by 54
“…and quercetin also removed senescent cells in vivo, improving outcomes in fibrotic pulmonary disease, reducing age-associated bone loss, improving physical function in old age, and improving outcomes after diabetic kidney disease (Schafer et al., 2017; Xu et al., 2018; Hickson et al., 2019).”
Mitochondrial Quality Control in Age-Related Pulmonary Fibrosis
Roque, W., Cuevas-Mora, K., & Romero, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020643 · Cited by 46
“Metabolic alterations seen in aging have also been found in the lungs of patients with IPF, raising the possibility that aging may contribute to the IPF pathogenesis [2].”
BackgroundKeeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 46
L’Hôte, V., Courbeyrette, R., Pinna, G., Cintrat, J., Le Pavec, G., Delaunay‐Moisan, A., Mann, C., & Thuret, J. (2021) · Aging Cell · doi:10.1111/acel.13447 · Cited by 37
“…senolytic treatment so far is the combination of dasatinib and quercetin, which in mice was shown to delay the onset of aging and to alleviate osteoporosis, idiopathic pulmonary fibrosis (IPF), and Alzheimer's disease (Farr et al., 2017; Musi et al., 2018; Schafer et al., 2017; Zhu et al., 2015).”
BackgroundFibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis
Nakahara, Y., Hashimoto, N., Sakamoto, K., Enomoto, A., Adams, T. S., Yokoi, T., Omote, N., Poli, S., Ando, A., Wakahara, K., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.03397-2020 · Cited by 49
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis
Burgy, O., Loriod, S., Beltramo, G., & Bonniaud, P. (2022) · Cells · doi:10.3390/cells11071209 · Cited by 51
“Leukotrienes are pro-inflammatory molecules that are part of the altered secretome of senescent cells observed during IPF [36,37].”
BackgroundYamada, Z., Nishio, J., Motomura, K., Mizutani, S., Yamada, S., Mikami, T., & Nanki, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935114 · Cited by 54
“senescent cells using genetically mutated mice or senolytics (31).”
BackgroundYuan, J.-H., Ma, Y., Yuan, L.-H., Gong, J., Xu, L., Wang, L.-V., & Jin, Y. (2023) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2160767 · Cited by 43
“of an increased and persistent number of senescent fibroblasts in lung tissues with IPF (Schafer et al. 2017).”
BackgroundInfluentialSalminen, A., Kaarniranta, K., & Kauppinen, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102296 · Cited by 53
Elimination of p19ARF‐expressing cells protects against pulmonary emphysema in mice
Mikawa, R., Suzuki, Y., Baskoro, H., Kanayama, K., Sugimoto, K., Sato, T., & Sugimoto, M. (2018) · Aging Cell · doi:10.1111/acel.12827 · Cited by 45
A tale of the good and bad: Cell senescence in bone homeostasis and disease
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.03.005 · Cited by 45
Pulmonary Complications of Rheumatoid Arthritis
Farquhar, H. J., Vassallo, R., Edwards, A. L., & Matteson, E. L. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1683995 · Cited by 56
Cellular senescence: friend or foe to respiratory viral infections?
Kelley, W. J., Zemans, R. L., & Goldstein, D. R. (2020) · European Respiratory Journal · doi:10.1183/13993003.02708-2020 · Cited by 45
Air Pollution—An Overlooked Risk Factor for Idiopathic Pulmonary Fibrosis
Majewski, S., & Piotrowski, W. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010077 · Cited by 49
“As a consequence, altered mitochondrial function leads to cell apoptosis and senescence, well known drivers of IPF [31].”
BackgroundThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Blokland, K. E. C., Nizamoglu, M., Habibie, H., Borghuis, T., Schuliga, M., Melgert, B. N., Knight, D. A., Brandsma, C.-A., Pouwels, S. D., & Burgess, J. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989169 · Cited by 45
“Both pro-inflammatory cytokines are involved in wound repair 465 and are identified as part of the SASP, which plays an important role in fibrosis (18, 56).”
BackgroundCellular senescence is increased in airway smooth muscle cells of elderly persons with asthma
Aghali, A., Khalfaoui, L., Lagnado, A. B., Drake, L. Y., Teske, J. J., Pabelick, C. M., Passos, J. F., & Prakash, Y. S. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00146.2022 · Cited by 44
Self-citationCellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
Zhang, Y., & Wang, J. (2023) · Advances in respiratory medicine · doi:10.3390/arm91010005 · Cited by 53
Macrophage-derived GPNMB trapped by fibrotic extracellular matrix promotes pulmonary fibrosis
Wang, J., Zhang, X., Min, L., Yuan, M., Yin, J., Luo, W. F., Wang, S., Cai, Y., Jiang, W., & Chao, J. (2023) · Communications Biology · doi:10.1038/s42003-022-04333-5 · Cited by 51
The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model
Hambright, W. S., Mu, X., Gao, X., Guo, P., Kawakami, Y., Mitchell, J., Mullen, M., Nelson, A.-L., Bahney, C., Nishimura, H., et al. (2023) · Journal of Osteoporosis · doi:10.1155/2023/5572754 · Cited by 44
The Impact of Aging in Acute Respiratory Distress Syndrome: A Clinical and Mechanistic Overview
Brown, R. R., McKelvey, M. C., Ryan, S. M., Creane, S., Linden, D. A., Kidney, J. C., McAuley, D. F., Taggart, C. C., & Weldon, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.589553 · Cited by 52
“In addition to vascular ECs, senescence of airway epithelial cells and fibroblasts has also been linked to the pathogenesis of idiopathic pulmonary fibrosis through their expression of pro-inflammatory and profibrotic factors (74).”
BackgroundKim, H., Jang, J., Song, M. J., Kim, G., Park, C.-H., Lee, D. H., Lee, S., & Chung, J. H. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18051 · Cited by 54
Reininger, D., Fundel‐Clemens, K., Mayr, C. H., Wollin, L., Laemmle, B., Quast, K., Nickolaus, P., & Herrmann, F. E. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17303 · Cited by 48
“…of the molecular pathways that were altered following treatment with nerandomilast, we integrated our RNA-seq data obtained from rat lung tissue treated with saline, bleo-mycin or bleomycin plus nerandomilast with human IPF RNA-seq data from the study conducted by Schafer et al. (2017).”
Lung regeneration: implications of the diseased niche and ageing
Melo-Narváez, M. C., Stegmayr, J., Wagner, D. E., & Lehmann, M. (2020) · European Respiratory Review · doi:10.1183/16000617.0222-2020 · Cited by 46
KLF4 regulates TERT expression in alveolar epithelial cells in pulmonary fibrosis
Wang, H., Xu, H., Lyu, W., Xu, Q., Fan, S., Chen, H., Wang, D., Chen, J., & Dai, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04886-7 · Cited by 50
Targeting tumor suppressor p53 for organ fibrosis therapy
Bao, Y., Yang, Q., Shen, X.-L., Yu, W.-K., Zhou, L., Zhu, Q.-R., Shan, Q., Wang, Z., & Cao, G. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06702-w · Cited by 51
O’Hara, S. P., Splinter, P. L., Trussoni, C. E., Guicciardi, M. E., Splinter, N. P., Alsuraih, M., Nasser‐Ghodsi, N., Stollenwerk, D., Gores, G. J., & LaRusso, N. F. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010176 · Cited by 43
Romashkan, S., Chang, H., & Hadley, E. C. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab028 · Cited by 50
“foci, telomere dysfunction, and SASP factors are associated with increased IPF severity (27).”
BackgroundPirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
Ballester, B., Milara, J., & Cortijo, J. (2020) · Oncotarget · doi:10.18632/oncotarget.27526 · Cited by 43
“Furthermore, both type of cells, fibroblasts and ATII cells, acquire senescent identities, which are able to promote lung fibrosis [6, 7].”
BackgroundVanadium pentoxide induced oxidative stress and cellular senescence in human lung fibroblasts
He, X., Jarrell, Z. R., Liang, Y., Smith, M. R., Orr, M. L., Marts, L. T., Go, Y., & Jones, D. P. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102409 · Cited by 43
The role of epithelial cells in fibrosis: Mechanisms and treatment
Luo, L., Zhang, W. Y., You, S., Cui, X. T., Tu, H., Qiao, Y., Wu, J., & Liu, O. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107144 · Cited by 50
Saul, D., Doolittle, M. L., Rowsey, J. L., Froemming, M. N., Kosinsky, R. L., Vos, S. J., Ruan, M. M., LeBrasseur, N. K., Chandra, A., Pignolo, R. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179834 · Cited by 49
Self-citationSystemic aging and aging‐related diseases
Li, Q., Xiao, N., Zhang, H., Liang, G., Lin, Y., Qian, Z., Yang, X. Y., Yang, J., Fu, Y., Zhang, C., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402479rrr · Cited by 59
Cellular senescence in tissue repair: every cloud has a silver lining
Yun, M. H. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180081my · Cited by 41
Wound senescence: A functional link between diabetes and ageing?
Wilkinson, H. N., & Hardman, M. J. (2020) · Experimental Dermatology · doi:10.1111/exd.14082 · Cited by 50
Cellular senescence: from anti-cancer weapon to anti-aging target
Yuan, L., Alexander, P. B., & Wang, X. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1629-6 · Cited by 42
Lv, X., Liu, C., Liu, S., Li, Y., Wang, W., Li, K., Hua, F., Cui, B., Zhang, X., Yu, J., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.015 · Cited by 50
Ting, C., Aspal, M., Vaishampayan, N., Huang, S. K., Riemondy, K. A., Wang, F., Farver, C. F., & Zemans, R. L. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.11.014 · Cited by 47
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 42
Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis
Kelich, J. M., Aramburu, T. M., van der Vis, J. J., Showe, L. C., Kossenkov, A. V., van der Smagt, J. J., Massink, M. P. G., Schoemaker, A. E., Hennekam, E. A. M., Veltkamp, M., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211681 · Cited by 46
Guo, H., Sun, J., Zhang, S., Nie, Y., Zhou, S., & Zeng, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205948 · Cited by 41
“Multiple murine models of pulmonary fibrosis display evidence of various cellular senescence markers, including heightened aging-associated β-galactosidase in lysosomes, an increased BCL-2/Bax ratio of apoptosis-involved proteins in mitochondria, and amplified DNA damage in the nucleus (Schafer et al., 2017; Blokland…”
BackgroundRole of cellular senescence in the pathogenesis of systemic sclerosis
Tsou, P., Shi, B., & Varga, J. (2022) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000898 · Cited by 44
“As shown in numerous studies, senescent IPF fibroblasts are less sensitive to cytotoxic and proapoptotic signals, resulting in their accumulation in tissues [64,72].”
BackgroundModeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades
Wirsdörfer, F., & Jendrossek, V. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0865-1 · Cited by 47
“These novel targets include for example danger signals, death resistance, progressive senescence, or immune deviation [12, 24, 26, 27].”
InfluentialTo stay young, kill zombie cells
Scudellari, M. (2017) · Nature · doi:10.1038/550448a · Cited by 46
Radiation-induced premature cellular senescence involved in glomerular diseases in rats
Aratani, S., Tagawa, M., Nagasaka, S., Sakai, Y., Shimizu, A., & Tsuruoka, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-34893-8 · Cited by 45
Feng, F., Wang, Z., Li, R., Wu, Q., Gu, C., Xu, Y., Peng, W., Han, D., Zhou, X., Wu, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108669 · Cited by 44
Metadata
- Authors
- Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., Mazula, D. L., Brooks, R. W., Fuhrmann-Stroissnigg, H., Pirtskhalava, T., Prakash, Y. S., Tchkonia, T., Robbins, P. D., Aubry, M. C., Passos, J. F., Kirkland, J. L., Tschumperlin, D. J., Kita, H., & LeBrasseur, N. K.
- Affiliations
- Mayo Clinic (US)
- Newcastle University (GB)
- Scripps Research Institute (US)
- Corresponding author
- LeBrasseur, Nathan K.
- ORCID
- Venue
- Nature Communications
- Published
- 2017-02-23
- Volume
- 8
- Issue
- 1
- Pages
- 14532-14532
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5331226
- OpenAlex
- W2591114726
- Cited by
- 1,613
- References
- 52
- Citations by year
- 2026: 195 · 2025: 205 · 2024: 193 · 2023: 193 · 2022: 192 · 2021: 181 · 2020: 176 · 2019: 128 · 2018: 107 · 2017: 42
- FWCI
- 91.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Mayo Clinic (UL1-TR000135)
- Glenn Foundation for Medical Research
- Louisiana Transportation Research Center
- Georgia Clinical and Translational Science Alliance (UL1 TR000135)
- Noaber Foundation
- Fondation pour la Recherche Médicale
- National Institutes of Health (UL1TR000135, 2r01hl092961-13)
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/K017314/1, BB/H022384/1)
- National Institute on Aging (R01AG053832, R01AG013925, R37AG013925)
- National Heart, Lung, and Blood Institute (R01-HL-092961)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- cellular senescence, idiopathic pulmonary fibrosis, senolytics, senescence-associated secretory phenotype, senescent fibroblasts, p16, bleomycin-induced lung injury, interstitial pulmonary fibrosis, suicide gene therapy, lung function
- MeSH terms
- Animals, Bleomycin, Fibroblasts, Humans, Lung, Male, Biomarkers, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Proteome, Mice, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.